Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 97 to 108 of 128 entries
Sorted by: Best Match Show Resources per page
Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives.

Current neurology and neuroscience reports

Dalgas U, Langeskov-Christensen M, Stenager E, Riemenschneider M, Hvid LG.
PMID: 31720862
Curr Neurol Neurosci Rep. 2019 Nov 13;19(11):88. doi: 10.1007/s11910-019-1002-3.

PURPOSE OF REVIEW: For many years, exercise was controversial in multiple sclerosis (MS) and thought to exacerbate symptoms and fatigue. However, having been found to be safe and effective, exercise has become a cornerstone of MS rehabilitation and may...

Cite
Dalgas U, Langeskov-Christensen M, Stenager E, et al. Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives. Curr Neurol Neurosci Rep. 2019;19(11):88doi: 10.1007/s11910-019-1002-3.
Dalgas, U., Langeskov-Christensen, M., Stenager, E., Riemenschneider, M., & Hvid, L. G. (2019). Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives. Current neurology and neuroscience reports, 19(11), 88. https://doi.org/10.1007/s11910-019-1002-3
Dalgas, Ulrik, et al. "Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives." Current neurology and neuroscience reports vol. 19,11 (2019): 88. doi: https://doi.org/10.1007/s11910-019-1002-3
Dalgas U, Langeskov-Christensen M, Stenager E, Riemenschneider M, Hvid LG. Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives. Curr Neurol Neurosci Rep. 2019 Nov 13;19(11):88. doi: 10.1007/s11910-019-1002-3. PMID: 31720862.
Copy Download .nbib Format: NLM
Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment.

Multiple sclerosis (Houndmills, Basingstoke, England)

Cohen JA, Trojano M, Mowry EM, Uitdehaag BM, Reingold SC, Marrie RA.
PMID: 31778094
Mult Scler. 2020 Jan;26(1):23-37. doi: 10.1177/1352458519892555. Epub 2019 Nov 28.

Randomized controlled clinical trials and real-world observational studies provide complementary information but with different validity. Some clinical questions (disease behavior, prognosis, validation of outcome measures, comparative effectiveness, and long-term safety of therapies) are often better addressed using real-world data...

Cite
Cohen JA, Trojano M, Mowry EM, et al. Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment. Mult Scler. 2019;26(1):23-37doi: 10.1177/1352458519892555.
Cohen, J. A., Trojano, M., Mowry, E. M., Uitdehaag, B. M., Reingold, S. C., & Marrie, R. A. (2020). Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment. Multiple sclerosis (Houndmills, Basingstoke, England), 26(1), 23-37. https://doi.org/10.1177/1352458519892555
Cohen, Jeffrey A, et al. "Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 26,1 (2020): 23-37. doi: https://doi.org/10.1177/1352458519892555
Cohen JA, Trojano M, Mowry EM, Uitdehaag BM, Reingold SC, Marrie RA. Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment. Mult Scler. 2020 Jan;26(1):23-37. doi: 10.1177/1352458519892555. Epub 2019 Nov 28. PMID: 31778094; PMCID: PMC6950891.
Copy Download .nbib Format: NLM
[No title available]

Revue medicale suisse

Gardier S.
PMID: 31617978
Rev Med Suisse. 2019 Oct 16;15(667):1892-1893.

No abstract available.

Cite
Gardier S. Traitements actuels de la sclérose en plaques : indications et surveillance. . Rev Med Suisse. 2019;15(667):1892-1893
Gardier, S. (2019). Traitements actuels de la sclérose en plaques : indications et surveillance. . Revue medicale suisse, 15(667), 1892-1893.
Gardier, Stéphany. "Traitements actuels de la sclérose en plaques : indications et surveillance." . Revue medicale suisse vol. 15,667 (2019): 1892-1893.
Gardier S. Traitements actuels de la sclérose en plaques : indications et surveillance. . Rev Med Suisse. 2019 Oct 16;15(667):1892-1893. French. PMID: 31617978.
Copy Download .nbib Format: NLM
Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees.

Multiple sclerosis and related disorders

Hua LH, Obeidat AZ, Longbrake EE.
PMID: 32585616
Mult Scler Relat Disord. 2020 Sep;44:102296. doi: 10.1016/j.msard.2020.102296. Epub 2020 Jun 10.

BACKGROUND: Neuroimmunology/multiple sclerosis is a rapidly evolving, but still poorly defined subspecialty. Fellowship training is not standardized, and there is substantial variability across sites. Outcomes of fellowship training have not yet been studied. We therefore examined early career choices...

Cite
Hua LH, Obeidat AZ, Longbrake EE. Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees. Mult Scler Relat Disord. 2020;44:102296doi: 10.1016/j.msard.2020.102296.
Hua, L. H., Obeidat, A. Z., & Longbrake, E. E. (2020). Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees. Multiple sclerosis and related disorders, 44102296. https://doi.org/10.1016/j.msard.2020.102296
Hua, Le H, et al. "Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees." Multiple sclerosis and related disorders vol. 44 (2020): 102296. doi: https://doi.org/10.1016/j.msard.2020.102296
Hua LH, Obeidat AZ, Longbrake EE. Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees. Mult Scler Relat Disord. 2020 Sep;44:102296. doi: 10.1016/j.msard.2020.102296. Epub 2020 Jun 10. PMID: 32585616; PMCID: PMC8023409.
Copy Download .nbib Format: NLM
Self-help Acceptance and Commitment Therapy for Carers of People with Multiple Sclerosis: A Feasibility Randomised Controlled Trial.

Journal of clinical psychology in medical settings

Potter KJ, Golijana-Moghaddam N, Evangelou N, Mhizha-Murira JR, das Nair R.
PMID: 32144616
J Clin Psychol Med Settings. 2021 Jun;28(2):279-294. doi: 10.1007/s10880-020-09711-x.

Acceptance and Commitment Therapy (ACT) is an established psychological therapy, but its effectiveness for carers of people with multiple sclerosis (MS) experiencing carer-related strain has not been established. This study assessed the acceptability and feasibility of conducting a randomised...

Cite
Potter KJ, Golijana-Moghaddam N, Evangelou N, et al. Self-help Acceptance and Commitment Therapy for Carers of People with Multiple Sclerosis: A Feasibility Randomised Controlled Trial. J Clin Psychol Med Settings. 2021;28(2):279-294doi: 10.1007/s10880-020-09711-x.
Potter, K. J., Golijana-Moghaddam, N., Evangelou, N., Mhizha-Murira, J. R., & das Nair, R. (2021). Self-help Acceptance and Commitment Therapy for Carers of People with Multiple Sclerosis: A Feasibility Randomised Controlled Trial. Journal of clinical psychology in medical settings, 28(2), 279-294. https://doi.org/10.1007/s10880-020-09711-x
Potter, Kristy-Jane, et al. "Self-help Acceptance and Commitment Therapy for Carers of People with Multiple Sclerosis: A Feasibility Randomised Controlled Trial." Journal of clinical psychology in medical settings vol. 28,2 (2021): 279-294. doi: https://doi.org/10.1007/s10880-020-09711-x
Potter KJ, Golijana-Moghaddam N, Evangelou N, Mhizha-Murira JR, das Nair R. Self-help Acceptance and Commitment Therapy for Carers of People with Multiple Sclerosis: A Feasibility Randomised Controlled Trial. J Clin Psychol Med Settings. 2021 Jun;28(2):279-294. doi: 10.1007/s10880-020-09711-x. PMID: 32144616; PMCID: PMC8192317.
Copy Download .nbib Format: NLM
Motivational interviewing to promote health outcomes and behaviour change in multiple sclerosis: a systematic review.

Clinical rehabilitation

Dorstyn DS, Mathias JL, Bombardier CH, Osborn AJ.
PMID: 31867992
Clin Rehabil. 2020 Mar;34(3):299-309. doi: 10.1177/0269215519895790. Epub 2019 Dec 23.

OBJECTIVE: To examine the evidence for motivational interviewing when used to assist individuals with multiple sclerosis manage their healthcare.DATA SOURCES: The Cochrane, Embase, PsycINFO and PubMed databases were searched for studies published between 1983 and December 2019. The reference...

Cite
Dorstyn DS, Mathias JL, Bombardier CH, et al. Motivational interviewing to promote health outcomes and behaviour change in multiple sclerosis: a systematic review. Clin Rehabil. 2019;34(3):299-309doi: 10.1177/0269215519895790.
Dorstyn, D. S., Mathias, J. L., Bombardier, C. H., & Osborn, A. J. (2020). Motivational interviewing to promote health outcomes and behaviour change in multiple sclerosis: a systematic review. Clinical rehabilitation, 34(3), 299-309. https://doi.org/10.1177/0269215519895790
Dorstyn, Diana S, et al. "Motivational interviewing to promote health outcomes and behaviour change in multiple sclerosis: a systematic review." Clinical rehabilitation vol. 34,3 (2020): 299-309. doi: https://doi.org/10.1177/0269215519895790
Dorstyn DS, Mathias JL, Bombardier CH, Osborn AJ. Motivational interviewing to promote health outcomes and behaviour change in multiple sclerosis: a systematic review. Clin Rehabil. 2020 Mar;34(3):299-309. doi: 10.1177/0269215519895790. Epub 2019 Dec 23. PMID: 31867992.
Copy Download .nbib Format: NLM
Continuous learning in multiple sclerosis care: a qualitative study of the expanded learning model for systems.

International journal of medical education

Ravyn D, Goodwin B, Lowney R.
PMID: 31256072
Int J Med Educ. 2019 Jun 28;10:122-128. doi: 10.5116/ijme.5cfa.29cb.

OBJECTIVES: This study characterized how an online continuing education activity affected knowledge, attitudes, and practices of healthcare professionals who care for patients with multiple sclerosis (MS) and whether those changes reflected theorized translational mechanisms proposed in The Expanded Learning...

Cite
Ravyn D, Goodwin B, Lowney R. Continuous learning in multiple sclerosis care: a qualitative study of the expanded learning model for systems. Int J Med Educ. 2019;10:122-128doi: 10.5116/ijme.5cfa.29cb.
Ravyn, D., Goodwin, B., & Lowney, R. (2019). Continuous learning in multiple sclerosis care: a qualitative study of the expanded learning model for systems. International journal of medical education, 10122-128. https://doi.org/10.5116/ijme.5cfa.29cb
Ravyn, Dana, et al. "Continuous learning in multiple sclerosis care: a qualitative study of the expanded learning model for systems." International journal of medical education vol. 10 (2019): 122-128. doi: https://doi.org/10.5116/ijme.5cfa.29cb
Ravyn D, Goodwin B, Lowney R. Continuous learning in multiple sclerosis care: a qualitative study of the expanded learning model for systems. Int J Med Educ. 2019 Jun 28;10:122-128. doi: 10.5116/ijme.5cfa.29cb. PMID: 31256072; PMCID: PMC6766394.
Copy Download .nbib Format: NLM
Immunotherapy of multiple sclerosis--current status and future perspectives. September 15, 1984, Zurich, Switzerland. Abstracts.

European neurology

[No authors listed]
PMID: 4065162
Eur Neurol. 1985;24(6):433-41. doi: 10.1159/000115838.
Free Article

No abstract available.

Cite
Immunotherapy of multiple sclerosis--current status and future perspectives. September 15, 1984, Zurich, Switzerland. Abstracts. Eur Neurol. 1985;24(6):433-41doi: 10.1159/000115838.
(1985). Immunotherapy of multiple sclerosis--current status and future perspectives. September 15, 1984, Zurich, Switzerland. Abstracts. European neurology, 24(6), 433-41. https://doi.org/10.1159/000115838
"Immunotherapy of multiple sclerosis--current status and future perspectives. September 15, 1984, Zurich, Switzerland. Abstracts." European neurology vol. 24,6 (1985): 433-41. doi: https://doi.org/10.1159/000115838
Immunotherapy of multiple sclerosis--current status and future perspectives. September 15, 1984, Zurich, Switzerland. Abstracts. Eur Neurol. 1985;24(6):433-41. doi: 10.1159/000115838. PMID: 4065162.
Copy Download .nbib Format: NLM
Treatment needed for multiple sclerosis.

The New England journal of medicine

Richter PL.
PMID: 4688383
N Engl J Med. 1973 Apr 05;288(14):740. doi: 10.1056/nejm197304052881419.

No abstract available.

Cite
Richter PL. Treatment needed for multiple sclerosis. N Engl J Med. 1973;288(14):740doi: 10.1056/nejm197304052881419.
Richter, P. L. (1973). Treatment needed for multiple sclerosis. The New England journal of medicine, 288(14), 740. https://doi.org/10.1056/nejm197304052881419
Richter, P L. "Treatment needed for multiple sclerosis." The New England journal of medicine vol. 288,14 (1973): 740. doi: https://doi.org/10.1056/nejm197304052881419
Richter PL. Treatment needed for multiple sclerosis. N Engl J Med. 1973 Apr 05;288(14):740. doi: 10.1056/nejm197304052881419. PMID: 4688383.
Copy Download .nbib Format: NLM
The nurse's role in the care of people with MS.

Nursing times

Sparrow S.
PMID: 9866583
Nurs Times. 1998 Oct 7-13;94(40):54-5.

No abstract available.

Cite
Sparrow S. The nurse's role in the care of people with MS. Nurs Times. 1998;94(40):54-5
Sparrow, S. (1998). The nurse's role in the care of people with MS. Nursing times, 94(40), 54-5.
Sparrow, S. "The nurse's role in the care of people with MS." Nursing times vol. 94,40 (1998): 54-5.
Sparrow S. The nurse's role in the care of people with MS. Nurs Times. 1998 Oct 7-13;94(40):54-5. PMID: 9866583.
Copy Download .nbib Format: NLM
Donald H Silberberg, MD.

Multiple sclerosis (Houndmills, Basingstoke, England)

Selzer ME.
PMID: 9345369
Mult Scler. 1996 Nov;2(4):171-2. doi: 10.1177/135245859600200401.

No abstract available.

Cite
Selzer ME. Donald H Silberberg, MD. Mult Scler. 1996;2(4):171-2doi: 10.1177/135245859600200401.
Selzer, M. E. (1996). Donald H Silberberg, MD. Multiple sclerosis (Houndmills, Basingstoke, England), 2(4), 171-2. https://doi.org/10.1177/135245859600200401
Selzer, M E. "Donald H Silberberg, MD." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 2,4 (1996): 171-2. doi: https://doi.org/10.1177/135245859600200401
Selzer ME. Donald H Silberberg, MD. Mult Scler. 1996 Nov;2(4):171-2. doi: 10.1177/135245859600200401. PMID: 9345369.
Copy Download .nbib Format: NLM
Clinical outcomes assessment in multiple sclerosis: Part II.

Multiple sclerosis (Houndmills, Basingstoke, England)

Cutter GR.
PMID: 9050365
Mult Scler. 1996 Dec;2(5):247-8. doi: 10.1177/135245859600200509.

No abstract available.

Cite
Cutter GR. Clinical outcomes assessment in multiple sclerosis: Part II. Mult Scler. 1996;2(5):247-8doi: 10.1177/135245859600200509.
Cutter, G. R. (1996). Clinical outcomes assessment in multiple sclerosis: Part II. Multiple sclerosis (Houndmills, Basingstoke, England), 2(5), 247-8. https://doi.org/10.1177/135245859600200509
Cutter, G R. "Clinical outcomes assessment in multiple sclerosis: Part II." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 2,5 (1996): 247-8. doi: https://doi.org/10.1177/135245859600200509
Cutter GR. Clinical outcomes assessment in multiple sclerosis: Part II. Mult Scler. 1996 Dec;2(5):247-8. doi: 10.1177/135245859600200509. PMID: 9050365.
Copy Download .nbib Format: NLM
Showing 97 to 108 of 128 entries